Diabetes 51:2420-2425, 2002
© 2002 by the American Diabetes Association, Inc.
The Antidiabetic Drug Metformin Activates the AMP-Activated Protein Kinase Cascade via an Adenine Nucleotide-Independent Mechanism
Simon A. Hawley1,
Anne E. Gadalla1,
Grith Skytte Olsen2, and
D. Grahame Hardie1
1 Division of Molecular Physiology, School of Life Sciences and Wellcome Trust Biocentre, Dundee University, Dundee, Scotland U.K.
2 Department of Diabetes Biology, NovoNordisk A/S, Bagsværd, Denmark
Metformin, a drug widely used to treat type 2 diabetes, was recently shown to activate the AMP-activated protein kinase (AMPK) in intact cells and in vivo. In this study we addressed the mechanism for this effect. In intact cells, metformin stimulated phosphorylation of the key regulatory site (Thr-172) on the catalytic ( ) subunit of AMPK. It did not affect phosphorylation of this site by either of two upstream kinases in cell-free assays, although we were able to detect an increase in upstream kinase activity in extracts of metformin-treated cells. Metformin has been reported to be an inhibitor of complex 1 of the respiratory chain, but we present evidence that activation of AMPK in two different cell types is not a consequence of depletion of cellular energy charge via this mechanism. Whereas we have not established the definitive mechanism by which metformin activates AMPK, our results show that the mechanism is different from that of the existing AMPK-activating agent, 5-aminoimidazole-4-carboxamide (AICA) riboside. Metformin therefore represents a useful new tool to study the consequences of AMPK activation in intact cells and in vivo. Our results also show that AMPK can be activated by mechanisms other than changes in the cellular AMP-to-ATP ratio.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Goransson, A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie, and K. Sakamoto
Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase
J. Biol. Chem.,
November 9, 2007;
282(45):
32549 - 32560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jager, C. Handschin, J. St.-Pierre, and B. M. Spiegelman
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha}
PNAS,
July 17, 2007;
104(29):
12017 - 12022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Buzzai, R. G. Jones, R. K. Amaravadi, J. J. Lum, R. J. DeBerardinis, F. Zhao, B. Viollet, and C. B. Thompson
Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth
Cancer Res.,
July 15, 2007;
67(14):
6745 - 6752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Kim, S.-Y. Park, J.-Y. Kim, J.-Y. Huh, W.-S. Jeon, C.-J. Yoon, S.-S. Yun, and K.-H. Moon
Metformin Restores the Penile Expression of Nitric Oxide Synthase in High-Fat-Fed Obese Rats
J Androl,
July 1, 2007;
28(4):
555 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, H. He, and J. A. Balschi
Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H457 - H466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Krawiec, G. J. Nystrom, R. A. Frost, L. S. Jefferson, and C. H. Lang
AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1555 - E1567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Mayes, M. F. Laforest, C. Guillemette, R. B. Gilchrist, and F. J. Richard
Adenosine 5'-Monophosphate Kinase-Activated Protein Kinase (PRKA) Activators Delay Meiotic Resumption in Porcine Oocytes
Biol Reprod,
April 1, 2007;
76(4):
589 - 597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Luo, G. J. Parker, R. C. Cooksey, Y. Soesanto, M. Evans, D. Jones, and D. A. McClain
Chronic Hexosamine Flux Stimulates Fatty Acid Oxidation by Activating AMP-activated Protein Kinase in Adipocytes
J. Biol. Chem.,
March 9, 2007;
282(10):
7172 - 7180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Towler and D. G. Hardie
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Circ. Res.,
February 16, 2007;
100(3):
328 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. U. Niesler, K. H. Myburgh, and F. Moore
Muscle: The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis
Exp Physiol,
January 1, 2007;
92(1):
207 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet, and U. A. Meyer
Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver
Mol. Pharmacol.,
December 1, 2006;
70(6):
1925 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Wong and H. F. Lodish
A Revised Model for AMP-activated Protein Kinase Structure: THE {alpha}-SUBUNIT BINDS TO BOTH THE beta- AND {gamma}-SUBUNITS ALTHOUGH THERE IS NO DIRECT BINDING BETWEEN THE beta- AND {gamma}-SUBUNITS
J. Biol. Chem.,
November 24, 2006;
281(47):
36434 - 36442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Lee, W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J.-M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, et al.
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States.
Diabetes,
August 1, 2006;
55(8):
2256 - 2264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Watt, G. R. Steinberg, Z.-P. Chen, B. E. Kemp, and M. A. Febbraio
Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes
J. Physiol.,
July 1, 2006;
574(1):
139 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue, and J.-L. Vanoverschelde
AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
Am J Physiol Heart Circ Physiol,
July 1, 2006;
291(1):
H239 - H250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Guigas, L. Bertrand, N. Taleux, M. Foretz, N. Wiernsperger, D. Vertommen, F. Andreelli, B. Viollet, and L. Hue
5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase-Independent Effect on Glucokinase Translocation.
Diabetes,
April 1, 2006;
55(4):
865 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Kim, J.-Y. Kim, Y.-H. Park, S.-Y. Park, K.-C. Won, K.-H. Choi, J.-Y. Huh, and K.-H. Moon
Metformin Restores Leptin Sensitivity in High-Fat-Fed Obese Rats With Leptin Resistance
Diabetes,
March 1, 2006;
55(3):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Sun, J. Y. Lee, P. I.W. de Bakker, N. P. Burtt, P. Almgren, L. Rastam, T. Tuomi, D. Gaudet, M. J. Daly, J. N. Hirschhorn, et al.
Haplotype Structures and Large-Scale Association Testing of the 5' AMP-Activated Protein Kinase Genes PRKAA2, PRKAB1, and PRKAB2 With Type 2 Diabetes
Diabetes,
March 1, 2006;
55(3):
849 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Hardie and K. Sakamoto
AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle
Physiology,
February 1, 2006;
21(1):
48 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Davis, Z. Xie, B. Viollet, and M.-H. Zou
Activation of the AMP-Activated Kinase by Antidiabetes Drug Metformin Stimulates Nitric Oxide Synthesis In Vivo by Promoting the Association of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase
Diabetes,
February 1, 2006;
55(2):
496 - 505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tosca, P. Froment, P. Solnais, P. Ferre, F. Foufelle, and J. Dupont
Adenosine 5'-Monophosphate-Activated Protein Kinase Regulates Progesterone Secretion in Rat Granulosa Cells
Endocrinology,
October 1, 2005;
146(10):
4500 - 4513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. C. van Loon, M. Thomason-Hughes, D. Constantin-Teodosiu, R. Koopman, P. L. Greenhaff, D. G. Hardie, H. A. Keizer, W. H. M. Saris, and A. J. M. Wagenmakers
Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E482 - E493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Woollhead, J. W Scott, D. G. Hardie, and D. L Baines
Phenformin and 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells
J. Physiol.,
August 1, 2005;
566(3):
781 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Detaille, B. Guigas, C. Chauvin, C. Batandier, E. Fontaine, N. Wiernsperger, and X. Leverve
Metformin Prevents High-Glucose-Induced Endothelial Cell Death Through a Mitochondrial Permeability Transition-Dependent Process
Diabetes,
July 1, 2005;
54(7):
2179 - 2187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. McCullough, Z. Zeng, H. Li, L. E. Landree, J. McFadden, and G. V. Ronnett
Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke
J. Biol. Chem.,
May 27, 2005;
280(21):
20493 - 20502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Croutch, M. Lebofsky, K.-W. Schramm, P. F. Terranova, and K. K. Rozman
2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and 1,2,3,4,7,8-Hexachlorodibenzo-p-Dioxin (HxCDD) Alter Body Weight by Decreasing Insulin-Like Growth Factor I (IGF-I) Signaling
Toxicol. Sci.,
May 1, 2005;
85(1):
560 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Frederich, L. Zhang, and J. A. Balschi
Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart
Am J Physiol Heart Circ Physiol,
May 1, 2005;
288(5):
H2412 - H2421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rencurel, A. Stenhouse, S. A. Hawley, T. Friedberg, D. G. Hardie, C. Sutherland, and C. R. Wolf
AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line
J. Biol. Chem.,
February 11, 2005;
280(6):
4367 - 4373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Altarejos, M. Taniguchi, A. S. Clanachan, and G. D. Lopaschuk
Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5'-AMP-activated Protein Kinase Kinase
J. Biol. Chem.,
January 7, 2005;
280(1):
183 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rafaeloff-Phail, L. Ding, L. Conner, W.-K. Yeh, D. McClure, H. Guo, K. Emerson, and H. Brooks
Biochemical Regulation of Mammalian AMP-activated Protein Kinase Activity by NAD and NADH
J. Biol. Chem.,
December 17, 2004;
279(51):
52934 - 52939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Leclerc and G. A. Rutter
AMP-Activated Protein Kinase: A New Beta-Cell Glucose Sensor?: Regulation by Amino Acids and Calcium Ions
Diabetes,
December 1, 2004;
53(suppl_3):
S67 - S74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zang, A. Zuccollo, X. Hou, D. Nagata, K. Walsh, H. Herscovitz, P. Brecher, N. B. Ruderman, and R. A. Cohen
AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells
J. Biol. Chem.,
November 12, 2004;
279(46):
47898 - 47905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Klein, S. Westphal, D. Kraus, B. Meier, N. Perwitz, V. Ott, M. Fasshauer, and H H. Klein
Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes
J. Endocrinol.,
November 1, 2004;
183(2):
299 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Hardie
The AMP-activated protein kinase pathway - new players upstream and downstream
J. Cell Sci.,
November 1, 2004;
117(23):
5479 - 5487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Zou, S. S. Kirkpatrick, B. J. Davis, J. S. Nelson, W. G. Wiles IV, U. Schlattner, D. Neumann, M. Brownlee, M. B. Freeman, and M. H. Goldman
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo: ROLE OF MITOCHONDRIAL REACTIVE NITROGEN SPECIES
J. Biol. Chem.,
October 15, 2004;
279(42):
43940 - 43951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Caballero, A. Delgado, C. A. Aguilar-Salinas, A. N. Herrera, J. L. Castillo, T. Cabrera, F. J. Gomez-Perez, and J. A. Rull
The Differential Effects of Metformin on Markers of Endothelial Activation and Inflammation in Subjects with Impaired Glucose Tolerance: A Placebo-Controlled, Randomized Clinical Trial
J. Clin. Endocrinol. Metab.,
August 1, 2004;
89(8):
3943 - 3948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tiikkainen, A.-M. Hakkinen, E. Korsheninnikova, T. Nyman, S. Makimattila, and H. Yki-Jarvinen
Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes
Diabetes,
August 1, 2004;
53(8):
2169 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakamoto, O. Goransson, D. G. Hardie, and D. R. Alessi
Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E310 - E317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. M. Chan, C.-L. M. Soltys, M. E. Young, C. G. Proud, and J. R. B. Dyck
Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte
J. Biol. Chem.,
July 30, 2004;
279(31):
32771 - 32779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pilon, P. Dallaire, and A. Marette
Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase: A NEW MECHANISM OF ACTION OF INSULIN-SENSITIZING DRUGS
J. Biol. Chem.,
May 14, 2004;
279(20):
20767 - 20774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
Glycemic Treatment: Control of glycemia
Diabetes Care,
May 1, 2004;
27(5):
1227 - 1234.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Brunmair, K. Staniek, F. Gras, N. Scharf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhausl, et al.
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I: A Common Mechanism Contributing to Their Antidiabetic Actions?
Diabetes,
April 1, 2004;
53(4):
1052 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Andersson, K. Filipsson, C. R. Abbott, A. Woods, K. Smith, S. R. Bloom, D. Carling, and C. J. Small
AMP-activated Protein Kinase Plays a Role in the Control of Food Intake
J. Biol. Chem.,
March 26, 2004;
279(13):
12005 - 12008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shang and M. A. Lehrman
Activation of Glycogen Phosphorylase with 5-Aminoimidazole-4-Carboxamide Riboside (AICAR): ASSESSMENT OF GLYCOGEN AS A PRECURSOR OF MANNOSYL RESIDUES IN GLYCOCONJUGATES
J. Biol. Chem.,
March 26, 2004;
279(13):
12076 - 12080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Frosig, S. B. Jorgensen, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski
5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle
Am J Physiol Endocrinol Metab,
March 1, 2004;
286(3):
E411 - E417.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Liu, B. J. Leffler, L. K. Weeks, G. Chen, C. M. Bouchard, A. B. Strawbridge, and J. S. Elmendorf
Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism
Am J Physiol Cell Physiol,
February 1, 2004;
286(2):
C317 - C329.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. B. Jorgensen, B. Viollet, F. Andreelli, C. Frosig, J. B. Birk, P. Schjerling, S. Vaulont, E. A. Richter, and J. F. P. Wojtaszewski
Knockout of the {alpha}2 but Not {alpha}1 5'-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-{beta}-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle
J. Biol. Chem.,
January 9, 2004;
279(2):
1070 - 1079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Adams, Z.-P. Chen, B. J.W. Van Denderen, C. J. Morton, M. W. Parker, L. A. Witters, D. Stapleton, and B. E. Kemp
Intrasteric control of AMPK via the {gamma}1 subunit AMP allosteric regulatory site
Protein Sci.,
January 1, 2004;
13(1):
155 - 165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Hardie
Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status
Endocrinology,
December 1, 2003;
144(12):
5179 - 5183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Ruderman, A. K. Saha, and E. W. Kraegen
Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity
Endocrinology,
December 1, 2003;
144(12):
5166 - 5171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yin, J. Mu, and M. J. Birnbaum
Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes
J. Biol. Chem.,
October 31, 2003;
278(44):
43074 - 43080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kovacic, C.-L. M. Soltys, A. J. Barr, I. Shiojima, K. Walsh, and J. R. B. Dyck
Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart
J. Biol. Chem.,
October 10, 2003;
278(41):
39422 - 39427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Christopher, Z.-P. Chen, C. Rantzau, B. E. Kemp, and F. P. Alford
Skeletal muscle basal AMP-activated protein kinase activity is chronically elevated in alloxan-diabetic dogs: impact of exercise
J Appl Physiol,
October 1, 2003;
95(4):
1523 - 1530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Zou, X.-Y. Hou, C.-M. Shi, S. Kirkpatick, F. Liu, M. H. Goldman, and R. A. Cohen
Activation of 5'-AMP-activated Kinase Is Mediated through c-Src and Phosphoinositide 3-Kinase Activity during Hypoxia-Reoxygenation of Bovine Aortic Endothelial Cells: ROLE OF PEROXYNITRITE
J. Biol. Chem.,
September 5, 2003;
278(36):
34003 - 34010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. El-Assaad, J. Buteau, M.-L. Peyot, C. Nolan, R. Roduit, S. Hardy, E. Joly, G. Dbaibo, L. Rosenberg, and M. Prentki
Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic {beta}-Cell Death
Endocrinology,
September 1, 2003;
144(9):
4154 - 4163.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|